First Trust NYSE Arca Biotechnology Index Fund
240 hedge funds and large institutions have $645M invested in First Trust NYSE Arca Biotechnology Index Fund in 2023 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 54 increasing their positions, 91 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less funds holding
Funds holding: →
9% less capital invested
Capital invested by funds: $707M → $645M (-$62.1M)
19% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 27
41% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 91
Holders
240
Holding in Top 10
2
Calls
$1.43M
Puts
$29K
Top Buyers
| 1 | +$31.7M | |
| 2 | +$2.72M | |
| 3 | +$2.52M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.04M |
| 5 |
AI
Atria Investments
Charlotte,
North Carolina
|
+$1.21M |
Top Sellers
| 1 | -$29.1M | |
| 2 | -$10.7M | |
| 3 | -$5.37M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$5.22M |
| 5 |
William Blair & Company
Chicago,
Illinois
|
-$2.36M |